Expertise in
19
conditions

Dr. Boris I. Medarov

Internal Medicine
Amc
47 New Scotland Ave, 
Albany, NY 
Accepting New Patients
Before you request
Expertise in
19
conditions
Amc
47 New Scotland Ave, 
Albany, NY 

Overview

Boris Medarov is a primary care provider, practicing in Internal Medicine in Albany, New York.

Dr. Medarov is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Pulmonary Hypertension, Asthma, Pulmonary Veno-Occlusive Disease, Gastrostomy, and Ureteroscopy.

He is actively involved in clinical research, co-authoring 17 peer reviewed articles and participating in 7 clinical trials. Dr. Medarov is currently accepting new patients.

Specialties

Internal Medicine

Licenses

Critical Care Medicine in CT

Hospital Affiliations

Columbia Memorial Hospital
Aurelia Osborn Fox Memorial Hospital
Rome Memorial Hospital, Inc
Albany Medical Center Hospital
Southwestern Vermont Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Amc
47 New Scotland Ave, Albany, NY 12208

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: April 02, 2026
Intervention Type: Drug
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
A Prospective, Multi-Center, Randomized, Controlled, Pivotal Trial to Validate the Safety and Efficacy of the Hemolung® Respiratory Assist System for COPD Patients Experiencing an Acute Exacerbation Requiring Ventilatory Support
Enrollment Status: Terminated
Publish Date: October 14, 2022
Intervention Type: Device
Study Phase: Not Applicable
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) in Heart Failure With Preserved Ejection Fraction (HFpEF)
Enrollment Status: Terminated
Publish Date: November 10, 2020
Intervention Type: Drug
Study Phase: Phase 3
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
An Open-label Extension Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF) - A Long-term Follow-up to Study TDE-HF-301
Enrollment Status: Terminated
Publish Date: October 22, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

17 Total Publications

An analysis of adverse events associated with Mandibular Repositioning Appliances (MRA)- study of the FDA Manufacturer and User Facility Device Experience (MAUDE) database.
An analysis of adverse events associated with Mandibular Repositioning Appliances (MRA)- study of the FDA Manufacturer and User Facility Device Experience (MAUDE) database.
Journal: Respiratory medicine
Published: April 13, 2025
Similar Doctors
Expertise in
19
conditions
Dr. Lee S. Shapiro
Internal Medicine
Expertise in
19
conditions
Dr. Lee S. Shapiro
Internal Medicine
Before you request

Malta Specialty Care Center-Neurology

6 Medical Park Dr Ste 203, 
Ballston Spa, NY 
 (24.5 miles away)
518-264-1200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Lee Shapiro is a primary care provider, practicing in Internal Medicine in Ballston Spa, New York. Dr. Shapiro is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Degos Disease, Scleroderma, Systemic Sclerosis (SSc), and Scleroma. Dr. Shapiro is currently accepting new patients.

Expertise in
28
conditions
Dr. William G. Alderisio
Internal Medicine
Expertise in
28
conditions
Dr. William G. Alderisio
Internal Medicine

Amc

47 New Scotland Ave, 
Albany, NY 
 (0.1 miles away)
518-262-5076
Languages Spoken:
English
See accepted insurances

William Alderisio is a primary care provider, practicing in Internal Medicine in Albany, New York. Dr. Alderisio is highly rated in 28 conditions, according to our data. His clinical expertise encompasses Ventricular Fibrillation, Paroxysmal Ventricular Fibrillation, Long QT Syndrome, Pacemaker Implantation, and Cardiac Ablation.

Expertise in
40
conditions
Dr. Robert S. Busch
Internal Medicine
Expertise in
40
conditions
Dr. Robert S. Busch
Internal Medicine

Podiatry Washington Avenue Extension

220 Washington Avenue Ext, 
Albany, NY 
 (4.6 miles away)
518-489-4704
Languages Spoken:
English
See accepted insurances

Robert Busch is a primary care provider, practicing in Internal Medicine in Albany, New York. Dr. Busch is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Cushing's syndrome, and Juvenile Primary Osteoporosis.

Frequently Asked Questions about Dr. Boris I. Medarov

How do I make an appointment with Dr. Boris I. Medarov?

You can book an appointment with Dr. Boris I. Medarov by calling their office at 518-262-5196. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Boris I. Medarov a top-rated expert for Pulmonary Hypertension?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Boris I. Medarov is classified as an Distinguished expert for Pulmonary Hypertension, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Boris I. Medarov specialize in?

While Dr. Boris I. Medarov is a Internal Medicine, they have specific expertise in Pulmonary Hypertension, Asthma, and Pulmonary Veno-Occlusive Disease. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Internal Medicine.

Does Dr. Boris I. Medarov participate in research or clinical trials?

Yes. Dr. Boris I. Medarov has published 17 articles and abstracts on conditions like Pulmonary Hypertension. You can view a list of Dr. Boris I. Medarov's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Boris I. Medarov accept my insurance?

Dr. Boris I. Medarov accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 518-262-5196 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Medarov's expertise for a condition
ConditionClose
    View All 15 Advanced Conditions
    View All 69 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile